What is CorMedix's increase (decrease) in accounts receivable?

CorMedix (CRMD) reported increase (decrease) in accounts receivable of -$16.45M in Q1 2026.

How has CorMedix's increase (decrease) in accounts receivable changed year-over-year?

CorMedix's increase (decrease) in accounts receivable decreased by 654.7% year-over-year, from $2.96M to -$16.45M.

What does increase (decrease) in accounts receivable mean?

The net change in the amount owed to the company by customers for goods or services delivered on credit. An increase typically indicates rising sales or potential delays in collection, while a decrease suggests effective cash collection cycles.

CorMedix CRMD Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

TFX

TeleflexTFX

$25.01M+129%

Baxter InternationalBAX

-$152M-485%

Merit Medical SystemsMMSI

——

HaemoneticsHAE

——

Medline, Inc. MDLN

——

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's increase (decrease) in accounts receivable?: CorMedix (CRMD) reported increase (decrease) in accounts receivable of -$16.45M in Q1 2026.
How has CorMedix's increase (decrease) in accounts receivable changed year-over-year?: CorMedix's increase (decrease) in accounts receivable decreased by 654.7% year-over-year, from $2.96M to -$16.45M.
What does increase (decrease) in accounts receivable mean?: The net change in the amount owed to the company by customers for goods or services delivered on credit. An increase typically indicates rising sales or potential delays in collection, while a decrease suggests effective cash collection cycles.